Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participantsmidwayadmin2020-05-15T15:34:56+00:00
Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants
TMB-365-101 · Trial ·
Major Inclusion/Exclusion Criteria:
- Have not been on HIV medication for past 3 months
- HIV RNA between 1,000 and 100,000 copies
- CD4 >350